Cargando…

Vitamin D levels in patients of acute leukemia before and after remission-induction therapy

Objectives: To determine the levels of 25-hydroxyvitamin [25(OH)D3] in patients with acute leukemia and the effect of remission-induction chemotherapy. Methodology: This study was case control, all newly diagnosed patients of acute leukemia between the age of one to sixty years and residents of Paki...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naz, Arshi, N. Qureshi, Rizwan, S. Shamsi, Tahir, Mahboob, Tabassum
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Professional Medical Publicaitons 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3809206/ https://www.ncbi.nlm.nih.gov/pubmed/24353499 http://dx.doi.org/10.12669/pjms.291.2764

Ejemplares similares

Outcomes of 1st Remission Induction Chemotherapy in Acute Myeloid Leukemia Cytogenetic Risk Groups
por: Zehra, Samreen, et al.
Publicado: (2016)

Comparison of serum levels of vitamin D and vitamin D-binding protein in normal, osteopenic and osteoporotic postmenopausal women
por: Murad, Rafat, et al.
Publicado: (2019)

TET2 mutations in acute myeloid leukemia: a comprehensive study in patients of Sindh, Pakistan
por: Shaikh, Abdul Rehman Khalil, et al.
Publicado: (2021)

Evaluation of efficacy of serological methods for detection of HCV infection in blood donors: A single centre experience
por: Naz, Arshi, et al.
Publicado: (2018)

Age and remission induction therapy for acute myeloid leukemia: An analysis of data from the Korean acute myeloid leukemia registry
por: Yoo, Kwai Han, et al.
Publicado: (2021)

Chasing quality remission in acute myeloid leukemia: intensity of induction and residual disease
por: Ofran, Yishai
Publicado: (2023)

Vitamin D Levels in Patients with Active and Remission Graves’ Disease
por: Rattanamusik, Natapon, et al.
Publicado: (2023)

Importance of immature platelet fraction as predictor of immune thrombocytopenic purpura
por: Naz, Arshi, et al.
Publicado: (2016)

Laboratory Diagnosis of Malaria: Comparison of Manual and Automated Diagnostic Tests
por: Mukry, Samina Naz, et al.
Publicado: (2017)

Pharmacogenomic Markers of Glucocorticoid Response in The Initial Phase of Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia
por: Gasic, Vladimir, et al.
Publicado: (2018)

Clinical Significance of Minimal Residual Disease at the End of Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia
por: Jovanovska, Aleksandra, et al.
Publicado: (2019)

Frequency of complete remission after standard 3+7 induction therapy in patients with acute myeloid leukemia
por: Shireen, Iram, et al.
Publicado: (2022)

Association of leukocyte nadir with complete remission in Indonesian acute myeloid leukemia patients undergoing 7+3 remission induction chemotherapy
por: Hadisantoso, Dwi Wahyunianto, et al.
Publicado: (2022)

Possible association of Vitamin D receptor, caudal-related homeobox 2 polymorphism with the risk of cancer
por: Rehman, Madiha, et al.
Publicado: (2021)

Improvement of Induction Remission Rate by Modifying the Dose of Idarubicin for Relapsed Childhood Acute Lymphoblastic Leukemia
por: Yoon, Jong Hyung, et al.
Publicado: (2009)

Economic analysis of oral posaconazole prophylaxis in acute myeloid leukemia during remission induction in Turkey
por: Umit, Elif Gulsum, et al.
Publicado: (2020)

BCL2 Expression at Post-Induction and Complete Remission Impact Outcome in Acute Myeloid Leukemia
por: Bilbao-Sieyro, Cristina, et al.
Publicado: (2020)

Redefining Remission Induction Chemotherapy Ineligibility by Early Mortality in De Novo Acute Myeloid Leukemia
por: Li, You-Cheng, et al.
Publicado: (2021)

Costs associated with adverse events from remission induction for children with Acute Lymphoblastic Leukemia (ALL)
por: Mejía-Aranguré, Eréndira, et al.
Publicado: (2022)

Can the Gene Expression Profile of Patients with Acute Myeloid Leukemia Predict Complete Remission Following Induction Therapy?
por: Sánchez-Sosa, Santiago, et al.
Publicado: (2022)

Serum vitamin D levels are decreased in patients without remission of Graves’ disease
por: Yasuda, Tetsuyuki, et al.
Publicado: (2012)

Diagnosis and phenotypic assessment of Pakistani Haemophilia B carriers
por: Khan, Muhammad Tariq Masood, et al.
Publicado: (2017)

Use of FLT3 inhibitors in acute myeloid leukemia remission induction or salvage therapy: systematic review and meta-analysis
por: Yang, Minglei, et al.
Publicado: (2018)

Complete remission with romidepsin in a patient with T‐cell acute lymphoblastic leukemia refractory to induction hyper‐CVAD
por: Brunvand, Mark W., et al.
Publicado: (2017)

PB1844: THROMBOTIC EVENTS DURING REMISSION INDUCTION OF ACUTE MYELOID LEUKEMIA – FREQUENCY AND RELATED FACTORS
por: Silva, W., et al.
Publicado: (2022)

Spontaneous hematological remission of acute myeloid leukemia
por: Kaźmierczak, Maciej, et al.
Publicado: (2014)

Salivary immunoglobulin A level during steroids and chemotherapy treatment administered in remission induction phase among pediatric patients with acute lymphoblastic leukemia
por: Proc, Patrycja, et al.
Publicado: (2020)

Prognostic Observational Analysis of BMI, Leptin, and Adiponectin in Children With Acute Lymphocytic Leukemia Undergoing Remission-Induction Chemotherapy
por: Sun, Jing, et al.
Publicado: (2022)

Association Between Serum Vitamin D Levels and Frequency of Relapses in Patients With Multiple Sclerosis
por: Mansoor, Farah, et al.
Publicado: (2021)

Optimizing survival outcomes with post‐remission therapy in acute myeloid leukemia
por: Medeiros, Bruno C., et al.
Publicado: (2019)

Expression Pattern of Long Non-coding RNA Growth Arrest-specific 5 in the Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia
por: Gasic, Vladimir, et al.
Publicado: (2019)

Medication errors in a cohort of pediatric patients with acute lymphoblastic leukemia on remission induction therapy in a tertiary care hospital in Mexico
por: Vázquez‐Cornejo, Edmundo, et al.
Publicado: (2019)

Vitamin D serum levels in allergic rhinitis: any difference from normal population?
por: Arshi, Saba, et al.
Publicado: (2012)

Incidence and Risk Factors for Breakthrough Invasive Mold Infections in Acute Myeloid Leukemia Patients Receiving Remission Induction Chemotherapy
por: Patel, Heena P, et al.
Publicado: (2019)

A novel vitamin D gene therapy for acute myeloid leukemia
por: Xu, Yi, et al.
Publicado: (2020)

Vitamin C and D supplementation in acute myeloid leukemia
por: Mouchel, Pierre Luc, et al.
Publicado: (2023)

Rhabdomyolysis and Acute Renal Impairment in a Patient with Hypothyroidism: A Case Report
por: Naz, Arshi, et al.
Publicado: (2014)

Immature Reticulocyte Fraction and Absolute Neutrophil Count as Predictor of Hemopoietic Recovery in Patients with Acute Lymphoblastic Leukemia on Remission Induction Chemotherapy
por: Rauf, Shan E., et al.
Publicado: (2016)

A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia
por: Wang, Amy Y., et al.
Publicado: (2018)

Spontaneous remission of acute lymphoblastic leukemia: A case report
por: Höres, Timm, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_amrehahdric579ulbj2cn24h8b